SCRPF(SCRPF)
SCRPF
No analyst ratings available
No analyst price targets available for SCRPF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2026E | FY2027E | FY2028E |
|---|---|---|---|
| Revenue Avg | $7.98B | $10.54B | $11.09B |
| Low | $6.03B | $7.00B | $7.80B |
| High | $8.98B | $11.83B | $12.47B |
| EBITDA Avg | $1.95B | $2.58B | $2.72B |
| Low | $1.48B | $1.71B | $1.91B |
| High | $2.20B | $2.90B | $3.06B |
| EBIT Avg | $1.46B | $1.93B | $2.03B |
| Low | $1.10B | $1.28B | $1.42B |
| High | $1.64B | $2.16B | $2.28B |
| Net Income Avg | $911M | $1.11B | $1.17B |
| Low | $560M | $681M | $720M |
| High | $1.06B | $1.29B | $1.36B |
| EPS Avg | $0.51 | $0.62 | $0.65 |
| Low | $0.31 | $0.38 | $0.40 |
| High | $0.59 | $0.72 | $0.76 |
| Analysts (Rev / EPS) | 13 / 1 | 13 / 1 | 7 / 1 |
| Metric | Q4 2026 | Q4 2027 | Q2 2028 | Q4 2028 |
|---|---|---|---|---|
| Revenue Avg | $4.36B | $3.48B | $3.45B | $3.48B |
| Low | $4.36B | $3.48B | $3.45B | $3.48B |
| High | $4.36B | $3.48B | $3.45B | $3.48B |
| EBITDA Avg | $1.07B | $852M | $846M | $852M |
| Low | $1.07B | $852M | $846M | $852M |
| High | $1.07B | $852M | $846M | $852M |
| EBIT Avg | $797M | $635M | $630M | $635M |
| Low | $797M | $635M | $630M | $635M |
| High | $797M | $635M | $630M | $635M |
| Net Income Avg | — | $502M | $599M | $502M |
| Low | — | $502M | $599M | $502M |
| High | — | $502M | $599M | $502M |
| EPS Avg | — | $0.28 | $0.33 | $0.28 |
| Low | — | $0.28 | $0.33 | $0.28 |
| High | — | $0.28 | $0.33 | $0.28 |
| Analysts (Rev / EPS) | 1 / — | 1 / 1 | 1 / 1 | 1 / 1 |